BACKGROUND: Use of prescription stimulants used to treat Attention Deficit/Hyperactivity Disorder (ADHD) for reasons other than prescribed, known as non-medical use, is a growing problem among undergraduates. Previous studies show that non-medical prescription stimulant (NMPS) users consume more alcohol than individuals who do not use NMPS. However, research on simultaneous use of NMPS and alcohol is limited. The objectives of this study were to: (1) determine the prevalence of simultaneous use of alcohol and NMPS; (2) examine predictors and consequences of simultaneous NMPS and alcohol use among undergraduates. METHODS:In fall 2009, 4090 students from eight North Carolina universities completed a web-based survey. RESULTS: Past year prevalence of NMPS use among this sample was 10.6% and simultaneous use of NMPS with alcohol was 4.9%. Among NMPS users, 46.4% used NMPS simultaneously with alcohol within the past year. Multivariable analysis revealed that simultaneous NMPS and alcohol use was associated with low grade point averages, use of other substances, and increased alcohol-related consequences. Simultaneous NMPSand alcohol users reported experiencing significantly more negative consequences than either past year drinkers who did not use prescription stimulants and concurrent NMPSand alcohol users (use over the past year but not at the same time). CONCLUSIONS: Simultaneous use of NMPS and alcohol is high among NMPS users in our sample of undergraduate students. Simultaneous users are at increased risk of experiencing negative consequences. Thus, prevention and intervention efforts should include a focus on simultaneous NMPS and alcohol use.
RCT Entities:
BACKGROUND: Use of prescription stimulants used to treat Attention Deficit/Hyperactivity Disorder (ADHD) for reasons other than prescribed, known as non-medical use, is a growing problem among undergraduates. Previous studies show that non-medical prescription stimulant (NMPS) users consume more alcohol than individuals who do not use NMPS. However, research on simultaneous use of NMPS and alcohol is limited. The objectives of this study were to: (1) determine the prevalence of simultaneous use of alcohol and NMPS; (2) examine predictors and consequences of simultaneous NMPS and alcohol use among undergraduates. METHODS: In fall 2009, 4090 students from eight North Carolina universities completed a web-based survey. RESULTS: Past year prevalence of NMPS use among this sample was 10.6% and simultaneous use of NMPS with alcohol was 4.9%. Among NMPS users, 46.4% used NMPS simultaneously with alcohol within the past year. Multivariable analysis revealed that simultaneous NMPS and alcohol use was associated with low grade point averages, use of other substances, and increased alcohol-related consequences. Simultaneous NMPS and alcohol users reported experiencing significantly more negative consequences than either past year drinkers who did not use prescription stimulants and concurrent NMPS and alcohol users (use over the past year but not at the same time). CONCLUSIONS: Simultaneous use of NMPS and alcohol is high among NMPS users in our sample of undergraduate students. Simultaneous users are at increased risk of experiencing negative consequences. Thus, prevention and intervention efforts should include a focus on simultaneous NMPS and alcohol use.
Authors: Christian J Teter; Sean Esteban McCabe; Kristy LaGrange; James A Cranford; Carol J Boyd Journal: Pharmacotherapy Date: 2006-10 Impact factor: 4.705
Authors: Timothy E Wilens; MaryKate Martelon; Amy Yule; Tamar A Kaminski; Colin Burke; Ty S Schepis; Sean E McCabe Journal: Am J Addict Date: 2020-05-20
Authors: Nicole Fossos-Wong; Jason R Kilmer; Alexander W Sokolovsky; Ha-Yoon Lee; Kristina M Jackson; Helene R White Journal: Subst Use Misuse Date: 2021-09-09 Impact factor: 2.362
Authors: Rachel S Wightman; Jeanmarie Perrone; Rachel Scagos; Benjamin D Hallowell; Maxwell Krieger; Yu Li; Alyson J McGregor; Lewis S Nelson; Brandon D L Marshall Journal: Drug Alcohol Depend Date: 2021-08-28 Impact factor: 4.852
Authors: Jason E Goldstick; Erin E Bonar; Matthew Myers; Amy S B Bohnert; Maureen A Walton; Rebecca M Cunningham Journal: J Stud Alcohol Drugs Date: 2022-01 Impact factor: 2.582